Mark Carey

Vancouver Coastal Health — Canada

Medicine · Health Sciences

41h-index9.7kcitations252works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(65), Cancer Cells and Metastasis(58), Cancer Genomics and Diagnostics(47), Cancer Mechanisms and Therapy(23), Gene expression and cancer classification(18)

Publications251 total

Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterations
Translational Oncology·2025Open Access
Endomyometrial resection for fertility preservation in patients with progestin-resistant atypical hyperplasia or grade 1 endometrioid endometrial cancer
Gynecologic Oncology·2025
Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilities
npj Precision Oncology·2025· 2 citedOpen Access
Pseudocyst Formation in Residual Ovary Syndrome: A Unique Consequence of Ovarian Preservation
Journal of Obstetrics and Gynaecology Canada·2025
Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analysis of Data from a Phase III Clinical Trial
Current Oncology·2025Open Access
Stratification of vulvar squamous cell carcinoma (VSCC) by HPV and P53 status to guide excision: CCTG VU.2 STRIVE study (NCT06358469).
Journal of Clinical Oncology·2025
Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilities
2025Open Access
Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumors
PLoS ONE·2025· 1 citedOpen Access
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype Study
2025· 1 citedOpen Access
Abstract 1689: Targeting PARP to enhance sensitivity to MEK inhibitors in low-grade serous ovarian cancer
Cancer Research·2025
FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma
Journal of Gynecologic Oncology·2025· 9 citedOpen Access
A scalable, multi-resolution consensus clustering approach for prioritising robust signals from high-throughput screens
2024Open Access
Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes
Frontiers in Oncology·2024· 2 citedOpen Access
Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer
Gynecologic Oncology·2024· 4 citedOpen Access
Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous Carcinoma
International Journal of Gynecological Pathology·2024· 6 cited
High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma
Gynecologic Oncology·2024· 9 citedOpen Access
The Development and Testing of a Patient Decision Aid for Individuals with Homologous Recombinant Proficient Ovarian Cancer Who Are Considering Niraparib Maintenance Therapy
Current Oncology·2024Open Access
Abstract B054: Defective STING signaling in low-grade serous ovarian cancer: an opportunity for oncolytic viruses therapy
Cancer Research·2024
DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas
Autophagy·2024· 13 citedOpen Access
Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery
International Journal of Gynecological Cancer·2023· 8 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Bryan T. Hennessy(22), Gordon B. Mills(21), Roshan Agarwal(8), David G. Huntsman(8), Marta Llauradó Fernández(8), Janice S. Kwon(7), Amy Dawson(7), Ana M. González-Angulo(6), Michael S. Anglesio(6), Katherine Stemke‐Hale(5), Joe W. Gray(5), Martin Köbel(5), Jessica N. McAlpine(5), Yiling Lu(5), Zhenlin Ju(5), C. Blake Gilks(5), Aňa Lluch(4), Ayşegül A. Şahin(4), Ju‐Seog Lee(4), Kirsten M. Timms(4)